+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cardiac Marker Market by Product (Instruments, Reagents & Kits), Biomarker Type (BNP Or NT-ProBNP, CK-MB, Hs-CRP), End-User, Indication - Forecast 2024-2030- Product Image
Global Cardiac Marker Market by Product (Instruments, Reagents & Kits), Biomarker Type (BNP Or NT-ProBNP, CK-MB, Hs-CRP), End-User, Indication - Forecast 2024-2030- Product Image
Sale

Global Cardiac Marker Market by Product (Instruments, Reagents & Kits), Biomarker Type (BNP Or NT-ProBNP, CK-MB, Hs-CRP), End-User, Indication - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337049
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiac Marker Market size was estimated at USD 3.81 billion in 2023, USD 4.16 billion in 2024, and is expected to grow at a CAGR of 9.71% to reach USD 7.29 billion by 2030.

Cardiac markers are substances or molecules measured in the blood to diagnose and monitor various cardiac conditions, particularly those related to heart muscle damage or stress. These markers are often used in clinical settings, such as hospitals and laboratories, to assist in diagnosing, prognosis, and monitoring cardiovascular diseases. They are particularly widely used in the diagnosis of conditions such as myocardial infarction and other forms of acute coronary syndrome. With an increased emphasis on accurate and early diagnosis in cases of cardiovascular diseases (CVD), the cardiac markers market's valuation has been progressively escalating. The rising incidence of cardiovascular conditions and the growing global geriatric population fuel the market demand for cardiac markers. Rising demand for point-of-care testing and the steady development in healthcare infrastructure, including well-equipped labs and trained personnel, globally aids the industry's growth. However, High prices associated with cardiovascular procedures and solutions affect market adoption. The evolution of the biomedical industry, particularly diagnostic technologies, and government healthcare initiatives and programs aiming to foster preventative care are instrumental in escalating the demand for cardiac markers and creating a significant growth opportunity for the market.

Regional Insights

The Americas has a significant market landscape in the cardiac marker market due to a high prevalence of cardiovascular diseases, well-established healthcare facilities, and major market players. The increasing incidence of heart attacks and the strong focus on early diagnosis and treatment are driving the demand for cardiac marker tests in this region. Moreover, advancements in the biotechnology sector and higher adoption rates for novel diagnostics methodologies contribute to America's cardiac marker market growth. Europe's market growth in the cardiac marker is propelled by the rising aging population, which is more prone to chronic diseases, including coronary heart disease. The availability of cutting-edge healthcare facilities, rising healthcare expenditures, and favorable regulatory policies also support the growth of the European cardiac marker market. Moreover, several key market players and ongoing research activities in the cardiac biomarkers space further stimulate market growth. The Asia-Pacific region is projected to show a significant cardiac marker market growth rate during the forecast period attributed to the large population base, the rising incidences of lifestyle diseases, and the gradual improvement in healthcare infrastructure across emerging economies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiac Marker Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiac Marker Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Marker Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aehealth Limited, Becton, Dickinson and Company, BG Medicine Inc., Bio-Rad Laboratories, Inc., Biomérieux SA, Danaher Corporation, DiaSorin S.P.A., HyTest Ltd., LSI Medience Corporation, PerkinElmer Inc., QuidelOrtho Corporation, Randox Laboratories Ltd., Roche Diagnostics Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Cardiac Marker Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
      • Chemiluminescence
      • ELISA
      • Immunochromatography
      • Immunofluorescence
    • Reagents & Kits
  • Biomarker Type
    • BNP Or NT-ProBNP
    • CK-MB
    • Hs-CRP
    • Myoglobin
    • Troponin I & T
  • End-User
    • Laboratory Testing Facilities
    • Point of Care Testing Facilities
  • Indication
    • Congestive Heart Failure
    • Myocardial Infarction
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Cardiac Marker Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiac Marker Market?
  3. What are the technology trends and regulatory frameworks in the Cardiac Marker Market?
  4. What is the market share of the leading vendors in the Cardiac Marker Market?
  5. Which modes and strategic moves are suitable for entering the Cardiac Marker Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cardiac Marker Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing occurrence of cardiovascular diseases
5.1.1.2. Accessibility to a large variety of reagents and kits for cardiac biomarkers
5.1.1.3. Improved healthcare infrastructure and spending across economies
5.1.2. Restraints
5.1.2.1. High prices associated with cardiovascular procedures and solutions
5.1.3. Opportunities
5.1.3.1. Ongoing advancements in cardiac markers
5.1.3.2. Persistent improvement in the essence of point-of-care diagnostic solution
5.1.4. Challenges
5.1.4.1. Stringent regulations and approvals for cardiac markers
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Cardiac Marker Market, by Product
6.1. Introduction
6.2. Instruments
6.3.1. Chemiluminescence
6.3.2. ELISA
6.3.3. Immunochromatography
6.3.4. Immunofluorescence
6.3. Reagents & Kits
7. Cardiac Marker Market, by Biomarker Type
7.1. Introduction
7.2. BNP Or NT-ProBNP
7.3. CK-MB
7.4. Hs-CRP
7.5. Myoglobin
7.6. Troponin I & T
8. Cardiac Marker Market, by End-User
8.1. Introduction
8.2. Laboratory Testing Facilities
8.3. Point of Care Testing Facilities
9. Cardiac Marker Market, by Indication
9.1. Introduction
9.2. Congestive Heart Failure
9.3. Myocardial Infarction
10. Americas Cardiac Marker Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cardiac Marker Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cardiac Marker Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Aehealth Limited
14.1.3. Becton, Dickinson and Company
14.1.4. BG Medicine Inc.
14.1.5. Bio-Rad Laboratories, Inc.
14.1.6. Biomérieux SA
14.1.7. Danaher Corporation
14.1.8. DiaSorin S.P.A.
14.1.9. HyTest Ltd.
14.1.10. LSI Medience Corporation
14.1.11. PerkinElmer Inc.
14.1.12. QuidelOrtho Corporation
14.1.13. Randox Laboratories Ltd.
14.1.14. Roche Diagnostics Ltd.
14.1.15. Siemens Healthineers AG
14.1.16. Thermo Fisher Scientific Inc.
14.1.17. Trinity Biotech PLC
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. CARDIAC MARKER MARKET RESEARCH PROCESS
FIGURE 2. CARDIAC MARKER MARKET SIZE, 2022 VS 2030
FIGURE 3. CARDIAC MARKER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CARDIAC MARKER MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. CARDIAC MARKER MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. CARDIAC MARKER MARKET DYNAMICS
FIGURE 7. CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2022 VS 2030 (%)
FIGURE 10. CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. CARDIAC MARKER MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 12. CARDIAC MARKER MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. CARDIAC MARKER MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 14. CARDIAC MARKER MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CARDIAC MARKER MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES CARDIAC MARKER MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. CARDIAC MARKER MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. CARDIAC MARKER MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. CARDIAC MARKER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. CARDIAC MARKER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIAC MARKER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 8. CARDIAC MARKER MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CARDIAC MARKER MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CARDIAC MARKER MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CARDIAC MARKER MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CARDIAC MARKER MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 14. CARDIAC MARKER MARKET SIZE, BY BNP OR NT-PROBNP, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CARDIAC MARKER MARKET SIZE, BY CK-MB, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CARDIAC MARKER MARKET SIZE, BY HS-CRP, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CARDIAC MARKER MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CARDIAC MARKER MARKET SIZE, BY TROPONIN I & T, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. CARDIAC MARKER MARKET SIZE, BY LABORATORY TESTING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CARDIAC MARKER MARKET SIZE, BY POINT OF CARE TESTING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 23. CARDIAC MARKER MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. CARDIAC MARKER MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. CANADA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 43. CANADA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 44. CANADA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. CANADA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. MEXICO CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 48. MEXICO CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CARDIAC MARKER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. CHINA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. CHINA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 70. CHINA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 71. CHINA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. CHINA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. INDIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. INDIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 75. INDIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 76. INDIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. INDIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. JAPAN CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. JAPAN CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 85. JAPAN CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 86. JAPAN CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. JAPAN CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. THAILAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. THAILAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 115. THAILAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 116. THAILAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. THAILAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. DENMARK CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. DENMARK CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 131. DENMARK CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. DENMARK CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. EGYPT CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. EGYPT CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 136. EGYPT CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 137. EGYPT CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. EGYPT CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. FINLAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. FINLAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 141. FINLAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 142. FINLAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. FINLAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. FRANCE CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. FRANCE CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 146. FRANCE CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. GERMANY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. GERMANY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. GERMANY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. ITALY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. ITALY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 161. ITALY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 162. ITALY CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. ITALY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. NORWAY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. NORWAY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 176. NORWAY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 177. NORWAY CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. NORWAY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. POLAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. POLAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 181. POLAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 182. POLAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. POLAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. QATAR CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. QATAR CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 186. QATAR CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 187. QATAR CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. QATAR CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. SPAIN CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. SPAIN CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 208. SPAIN CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. TURKEY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. TURKEY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 221. TURKEY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 234. CARDIAC MARKER MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 235. CARDIAC MARKER MARKET SHARE, BY KEY PLAYER, 2022
TABLE 236. CARDIAC MARKER MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Aehealth Limited
  • Becton, Dickinson and Company
  • BG Medicine Inc.
  • Bio-Rad Laboratories, Inc.
  • Biomérieux SA
  • Danaher Corporation
  • DiaSorin S.P.A.
  • HyTest Ltd.
  • LSI Medience Corporation
  • PerkinElmer Inc.
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.16 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.29 Billion
Compound Annual Growth Rate9.7%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Global Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Forecast 2024-2030 - Product Image

Global Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Cardiac Marker Testing Market by Biomarker (Troponin, CK-MB, BNP, hs-CRP, Myoglobin), Product (Instrument (Chemiluminescence, ELISA), Reagents & Kits), Disease (MI, CHF, Atherosclerosis), User, ASP & Buying Criteria - Global Forecast to 2028 - Product Image

Cardiac Marker Testing Market by Biomarker (Troponin, CK-MB, BNP, hs-CRP, Myoglobin), Product (Instrument (Chemiluminescence, ELISA), Reagents & Kits), Disease (MI, CHF, Atherosclerosis), User, ASP & Buying Criteria - Global Forecast to 2028

  • Report
  • 216 Pages
  • Global
From
Cardiac Marker Global Market Report 2024 - Product Image

Cardiac Marker Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Cardiac Marker Analyzer - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Cardiac Marker Analyzer - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Global Cardiac Marker Analyzer Market and Forecast, Impact of COVID-19, Product Analysis, Companies Business & Marketing Strategy, Major Deals - Product Image

Global Cardiac Marker Analyzer Market and Forecast, Impact of COVID-19, Product Analysis, Companies Business & Marketing Strategy, Major Deals

  • Report
  • 146 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.